627 related articles for article (PubMed ID: 314368)
1. The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients.
Bernengo MG; Capella G; de Matteis A; Tovo PA; Zina G
Clin Exp Immunol; 1979 May; 36(2):279-84. PubMed ID: 314368
[TBL] [Abstract][Full Text] [Related]
2. Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma.
Byrom NA; Campbell MA; Dean AJ; Timlin DM; Volkers C; Bodenham DC; Hobbs JR
Cancer Treat Rep; 1978 Nov; 62(11):1769-74. PubMed ID: 310343
[TBL] [Abstract][Full Text] [Related]
3. Thymic hormonal activity on human peripheral blood lymphocytes, in vitro. I. Reciprocal effect on T and B rosette formation.
Shoham J; Cohen M; Chandali Y; Avni A
Immunology; 1980 Oct; 41(2):353-9. PubMed ID: 6969219
[TBL] [Abstract][Full Text] [Related]
4. The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of patients with warts.
Bernengo MG; de Matteis A; Meregalli M; Capella G; Zina G
Br J Dermatol; 1980 Jan; 102(1):11-6. PubMed ID: 6966500
[TBL] [Abstract][Full Text] [Related]
5. In vitro lymphocyte reactivity and T cell levels in patients with melanoma: correlations with clinical and pathological stage.
Silverman NA; Alexander JC; Potvin C; Chretien PB
Surgery; 1976 Mar; 79(3):332-9. PubMed ID: 1083075
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
[TBL] [Abstract][Full Text] [Related]
7. T-dependent immunity in aged humans. II. Clinical and immunological evaluation after three months of administering a thymic extract.
Pandolfi F; Quinti I; Montella F; Voci MC; Schipani A; Urasia G; Aiuti F
Thymus; 1983 Apr; 5(3-4):235-40. PubMed ID: 6410547
[TBL] [Abstract][Full Text] [Related]
8. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
9. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
Sengar DP; Rashid A; Harris JE
Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
[TBL] [Abstract][Full Text] [Related]
10. T and B lymphocytes in myasthenia gravis.
Itoyama Y; Kawanami S; Goto I; Kuroiwa Y
Clin Exp Immunol; 1979 Sep; 37(3):452-6. PubMed ID: 315844
[TBL] [Abstract][Full Text] [Related]
11. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
Michalevicz R; Many A; Ramot B; Trainin N
Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
[TBL] [Abstract][Full Text] [Related]
12. Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration.
Müller-Berghaus J; Ehlert K; Ugurel S; Umansky V; Bucur M; Schirrmacher V; Beckhove P; Schadendorf D
Cancer Res; 2006 Jun; 66(12):5997-6001. PubMed ID: 16778169
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of thymosin on T cells from immunodepressed surgical patients.
Hardy MA; Freund M; Friedmann N
Surgery; 1976 Aug; 80(2):238-45. PubMed ID: 1085039
[TBL] [Abstract][Full Text] [Related]
14. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
Bodolay E; Berényi E; Sonkoly I; Szegedi G
Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
[TBL] [Abstract][Full Text] [Related]
15. Thymic hormone dependent immunodeficiency in an infant with partial trisomy of chromosome 22.
Tovo PA; Davi G; Fraceschini P; Delpiano A
Thymus; 1986; 8(5):313-8. PubMed ID: 3798528
[TBL] [Abstract][Full Text] [Related]
16. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.
Haanen JB; Baars A; Gomez R; Weder P; Smits M; de Gruijl TD; von Blomberg BM; Bloemena E; Scheper RJ; van Ham SM; Pinedo HM; van den Eertwegh AJ
Cancer Immunol Immunother; 2006 Apr; 55(4):451-8. PubMed ID: 16034562
[TBL] [Abstract][Full Text] [Related]
17. [An in-vitro system study of the immunomodulating activity of taktivin in atopic dermatitis].
Matushevskaia EV; Skriabina EG; Kubanova AA; Balo-Banga M
Vestn Dermatol Venerol; 1990; (9):9-11. PubMed ID: 2284871
[TBL] [Abstract][Full Text] [Related]
18. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
[TBL] [Abstract][Full Text] [Related]
19. [T-lymphocytes in the peripheral blood. Study on 113 patients with malignant melanoma].
Klein R; Krüger GR; Sesterhenn K
Z Hautkr; 1978 Feb; 53(3):62-6. PubMed ID: 305173
[TBL] [Abstract][Full Text] [Related]
20. Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
Di Nicola M; Carlo-Stella C; Mortarini R; Baldassari P; Guidetti A; Gallino GF; Del Vecchio M; Ravagnani F; Magni M; Chaplin P; Cascinelli N; Parmiani G; Gianni AM; Anichini A
Clin Cancer Res; 2004 Aug; 10(16):5381-90. PubMed ID: 15328176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
